Emergency Treatment of Haemorrhaging Coeliac or Mesenteric Artery Aneurysms and Pseudoaneurysms in the Era of Endovascular Management  by Roberts, K.J. et al.
Eur J Vasc Endovasc Surg (2015) 49, 382e389Emergency Treatment of Haemorrhaging Coeliac or Mesenteric Artery
Aneurysms and Pseudoaneurysms in the Era of Endovascular Management5
K.J. Roberts a, N. McCulloch a, C. Forde b, B. Mahon b, K. Mangat b, S.P. Olliff b, R.G. Jones b,*
a Department of Hepatobiliary and Pancreatic Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK
b Department of Radiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK5 Pr
tion, B
Britain
* Cor
mingha
Edgbas
E-ma
1078
Elsevie
http:WHAT THIS PAPER ADDS
This is the ﬁrst paper to describe the treatment and outcomes of an unselected consecutive series of symp-
tomatic visceral artery aneurysms where interventional radiology has been the primary modality. It documents a
5-year period at a high-volume specialist centre, with at least 12 months of follow-up. Morbidity and aneurysm-
related mortality are compared with studies where up-front surgery was the treatment of choice.Objectives: Patients requiring emergency treatment of visceral artery aneurysms (VAAs) can be treated by
endovascular or surgical techniques. Outcomes after failed attempts at endovascular control are unclear as is the
present role of surgery. This study reviewed treatment and outcomes of a contemporary cohort of patients with
symptomatic VAAs at a tertiary referral centre.
Methods: Patients undergoing emergency treatment of a VAA of the coeliac, mesenteric arteries, or their
branches were identiﬁed over a 5-year period. Patient variables, treatments, and outcomes were assessed.
Results: Forty-eight patients underwent 65 radiological and two surgical procedures. Pseuodaneuryms were
present in 45 (94%) of patients. Interventional radiology procedures were the initial treatment in every patient.
The initial success was 40 out of 48 (83%). Patients requiring more than one procedure were all successfully
treated. Regarding initial failures, if the VAA sac could not be accessed at angiography an alternative procedure
to control the VAA was required in every case. If initial endovascular treatment failed, repeating the same
procedure was successful in half of the patients. Ultrasound-guided percutaneous VAA embolisation was used in
four patients. The 30-day mortality was eight out of 48 (17%). There were four recorded complications including
one death directly attributable to VAA treatment.
Conclusions: Patients needing emergency treatment of a VAA could be well served by non-surgical management.
When the initial attempt at control of bleeding is unsuccessful it is important to consider non-conventional
means of accessing these arteries. The need for surgery, in selected centres, may exist for a small group of
patients after initial failed radiological treatment only.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Visceral artery aneurysms (VAAs) comprising true and
pseudoaneurysms are rare,1 with a reported incidence of
0.1e2%,2 and have the potential to cause life-threatening
haemorrhage if ruptured.3,4 Aetiology is varied and often
related to the vessel involved. Historical treatment of VAA
involved surgical management3 but has evolved towardsesented at the European-African Hepato-Pancreato-Biliary Associa-
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//dx.doi.org/10.1016/j.ejvs.2014.12.019less invasive techniques due to decreased morbidity and
mortality.4 Conservative management, which may include
observation of asymptomatic lesions, is now widely used.
Symptomatic VAAs however typically present with signs of
haemorrhage, cannot be simply observed, and require
emergency treatment. The treatment and outcomes of pa-
tients undergoing emergency treatment is different from
that for patients with asymptomatic VAA and thus cannot
be directly compared. Almost all previous studies have
grouped these patients together,2,5e15 however, making
interpretation of treatment and outcomes unclear.
Angiography with a view to embolisation or stent-graft
insertion is the main endovascular treatment option to
exclude these symptomatic aneurysms. These treatments
beneﬁt from low procedural morbidity and mortality and
have been shown to be highly successful but require specialist
personnel and equipment.7,15 Recent studies present a wide
Emergency Treatment of Mesenteric Aneurysms 383variety in the proportion of patients treated with endovas-
cular approaches or surgery as their initial management. At
one extreme, surgery was used in a few or no patients5e7 and
at the other in the majority.2,8,13 If initial endovascular man-
agement is unsuccessful patients can be managed with
repeated efforts at endovascular control, open surgery, or
rarely alternative minimally invasive techniques. There are
case reports of transabdominal ultrasound or endoscopic
ultrasound (EUS)-guided VAA injection and embolisation af-
ter failed endovascular treatment,7,16,17 although outcomes
among large consecutive series are lacking. Differing practice
between units, the period over which the study was con-
ducted, and the varying numbers of patients with asymp-
tomatic/symptomatic VAA in these studies renders
assessment of the current emergency treatment of symp-
tomatic VAA unclear.2,5,6,8e10,12,13,15,18 Endovascular man-
agement is well suited to the treatment of symptomatic
lesions given the minimally invasive nature of the treatment
and avoidance of surgery in inﬂamed tissues with major
haematoma inﬁltration.
There are also few data to show the outcomes after initial
failed attempts at endovascular treatment.9,11
The aim of this study therefore was to review the expe-
rience and outcomes of a contemporary cohort of patients
undergoing emergency treatment of a VAA at a high-
volume tertiary referral centre with a 24-hour interven-
tional radiology service. Treatment and outcomes were
identiﬁed, in particular the need for more than one pro-
cedure, for non-endovascular treatment, and complications.METHODS
This was a retrospective review of all patients with a VAA of
the coeliac or mesenteric arteries at a single high-volume
centre.Workload within this centre includes tertiary referral
services to provide liver transplantation, hepatobiliary and
pancreatic surgery, sarcoma surgery, vascular surgery, and
general surgery. All patients undergoing emergency treat-
ment (endovascular or surgical) of a symptomatic VAA were
included. Symptomatic VAAs were deﬁned as those pre-
senting with gastrointestinal haemorrhage (haematemesis,
malaena, or haemobilia) and peritoneal or retroperitoneal
haemorrhage due to the presence of the VAA. Owing to the
different treatment strategies and outcomes, patients with
asymptomatic VAA were excluded from the study.
Patients with VAAs were identiﬁed by searching all
electronic hospital radiology reports (both cross-sectional
imaging and interventional radiological procedures) for
the keywords “aneurysm”, “pseudoaneurysm”, or “emboli-
sation”. All positive reports were manually checked to verify
the nature of pathology and whether the patient was being
treated for a symptomatic VAA. It is possible that this
strategy might miss some patients whose computed to-
mography (CT) was performed at the local hospital and then
underwent surgical treatment. However many “outside” CT
reports are re-reported at this institution and patients
requiring surgery would have cross-sectional imaging at
some point to assess adequacy of treatment. Radiologyreports include an electronic description of the patient’s
history and previous treatment. Thus the only group of
patients at risk of not being identiﬁed are those with an
unreported outside CT scan undergoing surgical treatment
and dying without any postoperative radiological study
within the institution. Patient hospital records and elec-
tronic data (clinical observations, blood test results, oper-
ation notes, radiology procedures) were then reviewed
individually. Patients with a VAA of the coeliac, superior
mesenteric, or inferior mesenteric arteries or their branches
were included. Patients with renal or other artery VAAs
were not included. Subsequent treatment (surgery or
interventional radiology) was reviewed together with out-
comes, procedural failure/success, the need for further
intervention, complications, and mortality. The study period
was 5 years from January 1, 2008, to December 31, 2012.
There was a minimum 12-month follow-up for each patient.
Follow-up consisted of clinical review at 1, 3, 6, and 12
months (dependent upon the post-treatment clinical
course). A follow-up CT scan was typically performed at 3
months following all treatment to review the VAA.
The anatomical site, aetiology, treatment at the referring
institution, numberand typeof procedures, complications and
outcome were recorded. All radiology procedures were per-
formed by dedicated consultant interventional radiologists.Treatment algorithms
Patients were assessed and resuscitated using principals of
permissive hypotension.19 If a patient was haemodynami-
cally stable and with no evidence of contrast extravasation
at CT angiography they would typically undergo treatment
during the daytime; however, active extravastation of
contrast or haemodynamic instability would be treated at
that time. Once haemodynamically stable, if possible, with
or without general anaesthesia, patients would undergo a
CT scan with arterial enhancement in order to deﬁne and
understand the anatomy of the VAA prior to percutaneous
embolisation. If a bleeding site was identiﬁed, patients were
then moved to the endovascular suite for intervention.
Occasionally, patients too unwell for CT scan would proceed
directly to percutaneous angiography. The transfemoral
approach was used in all patients undergoing angiography.
This route permits a wide variety of catheters of different
shapes/sizes to selectively access the mesenteric vessels.
Angiography was then carried out with injection of iodin-
ated contrast through the catheter into the vessel to
delineate the vessel and any associated pathology. From
here embolisation materials (e.g. coils/glue) can be injected
through the catheter under ﬂuoroscopic guidance to treat
the aneurysm or pseudoaneurysm. Prior to embolisation
safe catheter tip position is essential to prevent non-target
embolisation of adjacent normal structures.
Coils are the ﬁrst choice of material to achieve embolisa-
tion with a typical 10% oversize in coil size comparedwith the
diameter of the vessel. Coil length depends on the anatomy
but frequently used lengths were 7 cm or 14 cm (Cook
medical Nestor coils, Bloomington, IN, USA). Smaller length
Table 1. Summary of cohort characteristics, presentation, aetiology
and anatomical location of the VAA.
Characteristic Whole
cohort
n ¼ 48
Need for
repeat
procedure
n ¼ 8
30 day
mortality
n ¼ 8
Male gender n (%) 30 (63%) 5 5
Age median (IQR) 61 (43e70)
Pseudoaneurysm 45 (94%) 8 7
Presentation
Haemorrhage 48 (100%) 8 8
Aetiology
Trauma 13 2 (s ¼ 1) 0
Pancreatitis 12 0 3
Idiopathic 6 2 2
Biliary sepsis 5 1 1
Post biopsy/TIPPS 3 0 1
POPF 3 0 1
Post liver transplant 2 1 (s ¼ 1) 0
Peptic ulcer 2 0 0
Mycotic 1 1 0
Coeliac artery stenosis 1 1 0
Site of VAA
Common hepatic 1 1 (s ¼ 1) 0
384 K.J. Roberts et al.coils were also available however. Histoacryl glues were used
selectively particularly when the body of the aneurysm or
pseudoaneurysm could be selectively catheterised rather
than injecting in the parent artery especially in the gastroin-
testinal tract vasculature. Polyvinyl alcohol particles are
rarely used in treating aneurysms or pseudoaneurysms.
In some patients, aneurysms (typically those with lesions
that could not be adequately treated by angiographic
techniques) were treated by direct percutaneous or endo-
scopic injection. There was no departmental protocol for
this, and so these cases are described in more detail in the
results section. Following the procedure, patients were
cared for in a high-dependency or intensive care setting.
Follow-up CT scans were performed to ensure satisfactory
treatment of the VAA in every case. Recurrent episodes of
hypotension, gastrointestinal bleeding, or falls in haemo-
globin triggered emergent CT imaging or repeated
angiography.
Data describing the cohorts were expressed as the median
(interquartile range) or absolute number and percentage.The
primary outcome of interest was 30-day mortality deﬁned as
the time from ﬁrst intervention at our institution.True hepatic 1 0 1
Right hepatic 14 1 2
Left hepatic 2 2 0
Intrahepatic 8 1 0
Dorsal pancreatic 1 0 1
Splenic 7 0 1
Intrasplenic 2 1 0
Gastroduodenal 7 0 1
IPDA 2 1 1
Jejunal/ileal 3 1 (s ¼ 1) 1
Note. (s ¼ n) denotes the numbers of patients undergoing surgical
treatment. IQR ¼ interquartile range; TIPPS ¼ transjugular
intrahepatic portosystemic shunt; POPF ¼ postoperative
pancreatic ﬁstula; IPDA ¼ inferior pancreaticoduodenal artery;
VAA ¼ visceral artery aneurysm.Deﬁnitions
In this manuscript interventional radiology procedures refer
to all angiographic and percutaneous procedures performed
under ultrasound or CT guidance.
RESULTS
Cohort characteristics
Forty-eight patients were identiﬁed, with 40 referred from
outside of our centre; three had treatment at the referring
hospital prior to transfer (endoscopic injection to a bleeding
duodenal ulcer, transarterial coil embolisation  2). Patient
variables, method of presentation, aetiology, and anatom-
ical site of the VAA are summarised in Table 1.Initial treatment and the need for further procedures
Interventional radiology was the initial treatment in all
patients: endovascular procedures n ¼ 47 and ultrasound
guided percutaneous injection n ¼ 1 (of an intrahepatic
VAA). Active bleeding was observed in 16 patients (33%).
All endovascular procedures were performed via the
common femoral artery. The radiological interventions were
as follows (some patients received more than 1 method of
embolisation): coils n ¼ 38, glue n ¼ 9, thrombin injection
n ¼ 4, polyvinyl alcohol particles n ¼ 3, gel foam n ¼ 1.
Stent-grafts were used in two patients (both 8-mm Viabahn
stents). Four aneurysms could not be successfully treated at
this initial attempt due to the inability to obtain a catheter
position to treat the VAA in three patients, and no possible
endovascular treatment was possible in one patient
(without occlusion of common hepatic artery post liver
transplant). All these patients required further treatment.
A further four patients required a second procedure
(total n ¼ 8, 17%; Table 2). The indication for the secondprocedure among these four patients was further haemor-
rhage. Six of these eight patients were treated with further
interventional radiology procedures (4 of whom had
ultrasound-guided embolisation). Of the three patients in
whom the VAA was not accessible at initial angiography, all
required a non-endovascular technique to control the
lesion. In those with an initial failed endovascular procedure
or missed bleeding point (n ¼ 3) subsequent repeat
endovascular treatment was successful in two patients.
Surgical intervention was required in two patients (4%).
In the ﬁrst patient bleeding occurred from a VAA of a caecal
branch of the ileocolic artery 2 weeks following severe blunt
polytrauma. At angiography no active bleeding was seen,
and coiling of what was thought to be the responsible VAA
was performed. Subsequently further gastrointestinal hae-
morrhage was treated with a right hemicolectomy. In the
second patient, open surgical excision and repair of a
common hepatic artery VAA was required 1 month post
liver transplant. Two further patients subsequently devel-
oped a new VAA at a different site.
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Emergency Treatment of Mesenteric Aneurysms 385Patients managed by non-endovascular, non-surgical
treatments
Patient 1. A stent-graft was placed across the origin of the
segment iv hepatic artery (which gave subsequent rise to
the intrahepatic VAA). Follow-up CT demonstrated persis-
tent VAA ﬁlling and following a re-bleed the patient had a
successful peripheral ultrasound-guided thrombin injection
to the VAA.
Patient 2. A VAA of the inferior pancreaticoduodenal artery,
in a patient with coeliac artery occlusion, required trans-
duodenal endoscopic ultrasound injection of histoacryl glue
after two failed attempts at endovascular control (Fig. 1Baec).
Patient 3. A VAA of the left hepatic artery was treated by
two percutaneous injections of thrombin under ultrasound
guidance after a failed attempt of endovascular control.
Patient 4. A VAA of the right hepatic artery required a
second percutaneous thrombin injection with coils under
ultrasound guidance after initial failed attempt at percuta-
neous injection.
Outcomes and complications
The median follow-up was 283 days (IQR 44e804), and at
last follow-up 13 (27%) patients had died. The 30-day
mortality was eight out of 48 (17%, summarised in
Table 3). Among these it was not possible to control hae-
morrhage in two patients who were too frail for other
treatment, and small bowel infarction secondary to embo-
lisation of glue occurred in one patient. The remainder died
due the underlying disease process with no evidence of
ongoing VAA haemorrhage at or before the time of death.
Regarding the ﬁve deaths occurring after 30 days, three
were of unknown causes after discharge, one of unrelated
causes after discharge, and one of late hepatic artery
thrombosis 2 years after hepatic artery reconstruction for
post liver transplant VAA of the hepatic artery.
Four complications, including one death, were related to
interventional radiology procedures and occurred following
65 procedures (6% of interventions or 8% of patients). One
patient with multi-organ failure secondary to necrotising
pancreatitis developed small bowel infarction due to glue
migration; one patient with a splenic artery VAA had com-
plete splenic infarction but did not require splenectomy;
one patient with a right hepatic artery VAA developed a
liver abscess following right lobe infarction requiring anti-
biotic therapy; and one patient with an intrahepatic VAA
developed a liver haematoma without clinical consequence.
DISCUSSION
This study reports the outcomes of consecutive patients
with symptomatic VAA undergoing emergency treatment at
a single centre with a dedicated interventional radiology
service as well as vascular, hepatobiliary/pancreatic/liver
transplant, and general surgery teams. The main ﬁndings
were that all initial attempts at treatment were non-surgical
and surgical treatment was required in less than 5% of
Figure 1. Examples of visceral artery aneurysms (VAAs) requiring treatment other than routine endovascular coil embolisation. Patient A:
endovascular stent. An idiopathic VAA of the right hepatic artery (A-a, solid arrow) could only be occluded by placement of an endo-
vascular stent (A-b, broken arrows). Patient B: EUS-guided injection. An IHPDA VAA after failed attempt at endovascular approaches. The
VAA is seen (B-a, bold arrow) at EUS and treated by direct injection of 3.5 ml histoacryl glue (B-b and -c, broken arrow). Patient C: pe-
ripheral coil embolisation. Haemorrhage two weeks following liver transplantation. The VAA is seen (C-a and eb, bold arrow). Arterial
contrast via the endovascular catheter (C-b, *) ﬁlls arterial branches (C-b, broken arrow), a portal vein branch (C-b, arrow head) and a
hepatic vein (C-c, arrow head). Extensive percutaneous coil embolisation was required to completely occlude the VAA (C-c and ed). Patient
D: peripheral coil embolisation and coil of ﬁstula track. The VAA is seen (bold arrow) as is an arteriobiliary ﬁstula (D-a, broken arrow) with
contrast seen in the biliary tree and left hepatic duct (D-a, arrow head). An external biliary drain is present (*). A microcoil successfully
occluded the ﬁstula (D-b, broken arrow). The VAA was then embolised with coils as was the needle track (D-c). Patient E: endovascular
injection. The VAA is seen (E-a and eb, bold arrow) as are liver packs (E-a and eb, broken arrow) used to control haemorrhage following
blunt trauma. The endovascular catheter went straight into the VAA (E-c) facilitating direct injection of 1.5 mL of histoacryl glue/lipiodol
mixture. The glue cast is seen in E-d (arrow head).
386 K.J. Roberts et al.patients. Procedural morbidity and mortality were present
but represented a small proportion of the overall morbidity
and mortality due to the underlying disease processes, and
thus interventional radiology for VAAs appears to be a
successful strategy with acceptable results. These results,
however, need to be considered in the context of this
specialist service at this high-volume tertiary referral centre.
No patient underwent surgery as an initial procedure
reﬂecting the shift in treatment of these lesions (a summaryof recent studies reporting the treatment and outcome of
patient cohorts with VAA is provided in the Supplementary
Table 1). Reports of endovascular repair have typically
excluded surgical patients6,7,9,12,20e22 and those that
include them have reported varying numbers of patients
initially treated with surgery.2,13,15,23 Despite widespread
use of endovascular treatments there are units with
recently published series where the majority of patients
have been treated with surgery.2,8,10,13 In the present
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Emergency Treatment of Mesenteric Aneurysms 387cohort of consecutive patients requiring emergency treat-
ment of VAA, all were initially treated with interventional
radiology procedures with surgery reserved for failures only.
Those centres predominately performing up-front surgery
(for a mix of elective and emergency VAAs) demonstrate
overall low rates of morbidity and mortality. Mortality can
reach 20e25% following surgery for bleeding VAAs8,18
however. The case for upfront surgery will be dictated by
the available interventional radiology service. Units with
high rates of success with endovascular procedures are
those with the lowest rates of surgical intervention (ref. 15
and the present study). In the largest published series of
endovascular treatment no patient underwent surgical
treatment after initial endovascular failure.7 Unfortunately,
it is not clear how many patients were treated with up-front
surgery as they were excluded from that study.
The 30-day mortality in the present series is comparable
with other series of predominately/sole endovascular
repair. Case mix makes direct comparison difﬁcult; however,
the vast majority of reported deaths are in patients with
haemorrhage. The present study includes only patients with
symptomatic VAA and haemorrhage thus mortality and
morbidity appear satisfactory. It is difﬁcult to draw clear
conclusions regarding the role of surgery and endovascular
treatment in this subgroup of emergency patients given
that this is a single-centre study where so few patients
underwent surgical treatment. The management of these
patients in this institution is to proceed directly to angiog-
raphy (with a prior CT angiogram if the patient is haemo-
dynamically stable) with or without intervention and then
select following treatment (if needed) on a case-by-case
basis with discussion between the relevant surgeons and
interventional radiologists. Further studies including pa-
tients only undergoing emergency treatment are required
to compare treatments and outcomes between units.
Nearly one in six patients did require more than one
procedure, however. The reasons for this were varied, but
the most common could be grouped into two distinct cate-
gories: failure to access the VAA radiologically or failure of
initial attempts at haemorrhage control. In the ﬁrst setting
successful control could only be achieved by alternative
means (ultrasound-guided injection and surgical repair) and
in the second scenario repeated attempts using the same
strategy seem justiﬁed as this yielded a satisfactory result in
half of these cases. For those patients where initial attempts
at endovascular control failed, the use of ultrasound-guided
VAA injection was an alternative treatment with no
morbidity and success in every case. One patient did require
a second thrombin injection to complete occlusion of the
VAA, 24 hours after initial injection. Some of these inter-
ventional procedures where treatment other than routine
endovascular embolisation was required are demonstrated
in Fig. 1. It is important to note that the above groups consist
of small patient numbers and thus conclusions drawn must
be interpreted in this light. However, with no prospective or
randomised trials of treatment of VAAs upon which to draw
conclusions, retrospective series such as this are essential to
report outcomes of contemporary and modern management
388 K.J. Roberts et al.approaches of uncommon diseases such as VAAs. Future
studies could be improved by reporting multicentre out-
comes and by the development of a prospective multicentre
database.
Other groups have debated criteria upon which to select
VAA for treatment7,15; the main point of discussion is
whether historical criteria used to select patients for sur-
gical repair14,24 are applicable in the era of endovascular
treatment. Clearly symptomatic VAAs do require treatment
and it appears that endovascular repair is associated with
low rates of morbidity, mortality, and high success. Those
studies with a high proportion of asymptomatic patients
reporting elective endovascular repair show lower
morbidity and no mortality in that setting.7,15 It has been
reported that pseudoaneurysms have a higher risk of
bleeding than true aneurysms,9,25 that the size of pseu-
doaneurysm does not correlate with bleeding risk,26 and
that bleeding risk is related to the artery involved.9
With no robust trials involving treatment of symptomatic
VAAs upon which to draw conclusions, retrospective series
such as this are essential to report outcomes of contem-
porary and modern management approaches of uncommon
diseases such as VAAs. Future studies could be improved by
reporting multicentre outcomes and by the development of
a prospective multicentre database.
Weaknesses of the study include confounding due to
local referral patterns and its retrospective nature. How-
ever, this problem is likely to affect all published series to
some degree as they present data from specialist centres.
With the retrospective study design it is possible that some
patients with VAAs were missed. Since the use of radiology
is common to all hospital speciality teams and that cross-
sectional imaging is essential to understand the anatomy
of VAAs and the post-procedure/postoperative manage-
ment of patients with VAAs, by searching all electronic
radiology records for keywords all patients with a VAA
should have been identiﬁed.
CONCLUSION
At this tertiary referral centre with a dedicated interven-
tional radiology service, all patients requiring emergency
treatment of their VAA were initially treated with inter-
ventional radiology procedures. Success was high and pro-
cedural morbidity and mortality appear to be low in this
setting though repeated procedures were not uncommon.
Further studies are required to review the present role of
interventional radiology and surgical procedures and their
outcomes in services with different levels of access to
interventional radiology services. It is essential that patients
requiring elective or emergency treatment are separated to
allow interpretation of these results.
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